What is FOXX LIFE SCIENCES?
Headquartered in the proximity of the Boston biotech hub, Foxx Life Sciences operates as a premier manufacturer of custom single-use systems, including advanced tubing, bag, bottle, and flask assemblies. The company maintains a rigorous commitment to quality, evidenced by its ISO 13485 certification and the utilization of ISO Class 7 cleanrooms. Serving the research, biotech, and pharmaceutical sectors, Foxx provides essential fluid management and laboratory safety solutions that are foundational to modern drug development and manufacturing processes. Their ability to deliver bespoke assemblies makes them a vital partner for organizations requiring precision and compliance in their laboratory infrastructure.
How much funding has FOXX LIFE SCIENCES raised?
FOXX LIFE SCIENCES has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in FOXX LIFE SCIENCES
PPP
Public-Private Partnership
What's next for FOXX LIFE SCIENCES?
With the infusion of this latest capital, Foxx Life Sciences is expected to scale its manufacturing capabilities to meet the surging demand for single-use technologies in the pharmaceutical industry. The strategic focus will likely center on enhancing production throughput within their cleanroom facilities and broadening their portfolio of fluid management products. As the industry shifts toward more flexible, modular manufacturing environments, Foxx is strategically aligned to capture additional market share by providing the critical components necessary for efficient, contamination-free bioprocessing. Future growth will likely be driven by continued investment in R&D and the expansion of their global distribution network to support the evolving needs of their life science clientele.
See full FOXX LIFE SCIENCES company page
